Clinical Trials Browser

Completed × INDUSTRY × Interventional × Clear all

NCT00600496 2026-05-27

A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)

Phase 1 Completed

BreastDermatologicGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Colonic Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms

NCT02231749 2026-05-27

Nivolumab Combined With Ipilimumab Versus Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (CheckMate 214)

Phase 3 Completed

1,096 enrolled 17 charts 1 FDA

Carcinoma, Renal Cell

NCT04980495 2026-05-27

ADAPT NXT

Phase 3 Completed

69 enrolled 10 charts

Myasthenia Gravis

NCT05015608 2026-05-27

SACHI

Phase 3 Completed

Carcinoma, Non-Small-Cell Lung

NCT05052801 2026-05-27

FORTITUDE-101

Phase 3 Completed

Gastrointestinal

Stomach Neoplasms

NCT05181462 2026-05-27

TRIFOUR

Phase 1/2 Completed

Triple Negative Breast Neoplasms

NCT06266143 2026-05-27

A Trial of Y101D in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Advanced Pancreatic Cancer

Phase 1/2 Completed

Gastrointestinal

Advanced Pancreatic Adenocarcinoma

NCT06461663 2026-05-27

CairnSurgical Breast Cancer Locator (BCL) Post-Market Study

Phase NA Completed

35 enrolled 10 charts

Breast Neoplasms

NCT06619873 2026-05-27

A Clinical Study to Evaluate the Relative Bioavailability and Food Effect of HRS-8080 in Healthy Subjects

Phase 1 Completed

Breast Neoplasms

NCT05064059 2026-05-26

MK-4280A-007

Phase 3 Completed

441 enrolled 24 charts

Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colorectal Neoplasms

NCT01946477 2026-05-22

POM MM 014

Phase 2 Completed

186 enrolled 17 charts

Multiple Myeloma, Neoplasms, Plasmacytoma

NCT03260894 2026-05-22

Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)

Phase 3 Completed

129 enrolled 13 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Renal Cell

NCT04053205 2026-05-22

A Study of Gentuximab + Paclitaxel in Patients With Advanced Gastric or Gastroesophageal Junction Cancer

Phase 1/2 Completed

Gastrointestinal

Advanced Gastric or Gastroesophageal Junction Cancer

NCT04846920 2026-05-22

MK-6482-018

Phase 1 Completed

Carcinoma, Renal Cell

NCT05848011 2026-05-22

A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms, Castration-Resistant

NCT06188559 2026-05-22

A Study of BB-1701 in Previously Treated Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive or HER2-low Unresectable or Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT05301764 2026-05-20

A Study of LVGN6051 Combined With Anlotinib in Patient With Soft Tissue Sarcoma

Phase 1/2 Completed

Sarcoma

NCT05534620 2026-05-20

Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics

Phase 1 Completed

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05900986 2026-05-20

LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer

Phase 1/2 Completed

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Carcinoma, Ductal, Breast

NCT06540807 2026-05-20

SafeHeal Anastomosis Feasibility Evaluation (SAFE)-2023 Study

Phase NA Completed

24 enrolled 6 charts

Gastrointestinal

Colorectal Neoplasms

NCT00629759 2026-05-19

A Study of Recombinant Vaccinia Virus to Evaluate the Safety and Efficacy of a Transdermal Injection Within the Tumor of Patients With Primary or Metastatic Hepatic Carcinoma

Phase 1 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Vaccinia

NCT02504489 2026-05-19

DUBLIN-3

Phase 3 Completed

559 enrolled 32 charts

Carcinoma, Non-Small-Cell Lung

NCT04130542 2026-05-19

Phase 1 Trial of LVGN6051 as Single Agent and in Combination With Keytruda (Pembrolizumab) in Advanced or Metastatic Malignancy

Phase 1 Completed

Neoplasms

NCT04635995 2026-05-19

Phase 1 Trial of LVGN7409 (CD40 Agonist Antibody) as Single Agent and Combination Therapies in Advanced or Metastatic Malignancy

Phase 1 Completed

Neoplasms

NCT06713564 2026-05-19

A Single Dose, Open-Label, Dose-escalation Study of the Safety and Imaging Characteristics of LS301-IT for Intraoperative Imaging of Lung Cancer

Phase 1 Completed

Lung Neoplasms

NCT07597759 2026-05-19

Phase IIT Trial of SNA009

Phase EARLY_PHASE1 Completed

Gastrointestinal

Colorectal Neoplasms

NCT03409614 2026-05-18

Combinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in Patients With Lung Cancer

Phase 3 Completed

789 enrolled 32 charts 1 FDA

Carcinoma, Non-Small-Cell Lung

NCT04305470 2026-05-18

MEN-301

Phase 3 Completed

108 enrolled 12 charts

Meningioma

NCT04742101 2026-05-18

Phase I/II Trial of S65487 Plus Azacitidine in Acute Myeloid Leukemia

Phase 1/2 Completed

Other hematologic neoplasm

Neoplasms, Leukemia, Myeloid, Acute

NCT02993523 2026-05-15

Viale-a

Phase 3 Completed

443 enrolled 14 charts 1 FDA

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT03910660 2026-05-15

A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.

Phase 1/2 Completed

EndocrineGenitourinaryNET

Prostatic Neoplasms, Carcinoma, Small Cell, Neuroendocrine Tumors

NCT04843709 2026-05-15

A Study of MRG004A in Patients With Tissue Factor Positive Advanced or Metastatic Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Advanced or Metastatic Solid Tumors

NCT05173142 2026-05-15

A Phase Ib/II Clinical Study Evaluating HMPL-453 Tartrate as Monotherapy and in Combination With Chemotherapy or Toripalimab in Advanced Solid Tumors

Phase 1/2 Completed

Gastrointestinal

Stomach Neoplasms

NCT01222286 2026-05-14

KIRMONO

Phase 2 Completed

30 enrolled 10 charts

Smoldering Multiple Myeloma

NCT01742299 2026-05-14

Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator

Phase 4 Completed

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT02297438 2026-05-14

A Study Of Palbociclib (PD-0332991) + Letrozole VS. Placebo+ Letrozole For 1st Line Treatment Of Asian Postmenopausal Women With ER+/HER2- Advanced Breast Cancer [PALOMA-4]

Phase 3 Completed

340 enrolled 33 charts

Breast Neoplasms, Neoplasm Metastasis

NCT03570892 2026-05-14

BELINDA

Phase 3 Completed

330 enrolled 10 charts

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT04246177 2026-05-14

LEAP-012

Phase 3 Completed

Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Hepatocellular

NCT05779163 2026-05-14

A Phase I/II Clinical Trial of LBL-033 in the Treatment of Advanced Malignant Tumors

Phase 1/2 Completed

Advanced Malignant Tumors

NCT07454863 2026-05-14

A Mass Balance Study of DZD8586 in Healthy Male Participants (TAI-SHAN15)

Phase 1 Completed

Lymphoma, Non-Hodgkin

NCT01009840 2026-05-13

IV Busulfan Plus Bortezomib Conditioning Regimen for Second Autologous Stem Cell Transplant in Multiple Myeloma Patients

Phase 2 Completed

30 enrolled 14 charts

Multiple Myeloma

NCT02362035 2026-05-13

KEYNOTE145

Phase 1/2 Completed

161 enrolled 29 charts

LymphoidOther hematologic neoplasmPlasma cell

Burkitt Lymphoma, Hodgkin Disease, Leukemia, Hairy Cell, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell

NCT02797795 2026-05-13

A Phase 1, Open-Label, Dose-Escalation Study of NEV801, Administered to Patients With Advanced Cancers

Phase 1 Completed

Other solid neoplasm

Advanced Cancer

NCT04093596 2026-05-13

UNIVERSAL

Phase 1 Completed

Multiple Myeloma

NCT04165096 2026-05-13

MK-3475-01C

Phase 2 Completed

128 enrolled 14 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

NCT04322006 2026-05-13

A Phase I/II Study of TJ004309 for Advanced Solid Tumor

Phase 1/2 Completed

Other solid neoplasm

Advanced Solid Tumor

NCT04756037 2026-05-13

SERENE

Phase 3 Completed

1,164 enrolled 16 charts

Endometriosis, Leiomyoma

NCT05153239 2026-05-13

Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON)

Phase 3 Completed

Small Cell Lung Carcinoma

NCT05231278 2026-05-13

CLEAR

Phase NA Completed

Lung Neoplasms

NCT05673460 2026-05-13

MK-1026-002

Phase 1 Completed

7 enrolled 15 charts

Mature B-cell Neoplasms